| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0005 |